• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

作者信息

Pilote L, Califf R M, Sapp S, Miller D P, Mark D B, Weaver W D, Gore J M, Armstrong P W, Ohman E M, Topol E J

机构信息

Cleveland Clinic Foundation, OH 44195, USA.

出版信息

N Engl J Med. 1995 Aug 31;333(9):565-72. doi: 10.1056/NEJM199508313330907.

DOI:10.1056/NEJM199508313330907
PMID:7623907
Abstract

BACKGROUND

Differences in the management of acute myocardial infarction have been reported among countries, but few studies have investigated this issue in regions of the United States.

METHODS

We compared the management of acute myocardial infarction among census regions across the United States, using data from the first Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries trial (GUSTO-1) comprising 21,772 patients, and from the American Hospital Association.

RESULTS

We found substantial regional variation in the management of acute myocardial infarction in the United States. Beta-blockers (prescribed for a range of 55 to 81 percent of patients in the various regions), nitrates (prescribed for 61 to 77 percent), and angiotensin-converting-enzyme inhibitors (prescribed for 18 to 23 percent) were used most often in New England, whereas calcium-channel blockers (31 to 42 percent) and lidocaine (14 to 43 percent) were used least often there. Similarly, the proportion of patients undergoing various cardiac procedures differed among regions (range for angiography, 52 to 81 percent of patients; angioplasty, 22 to 35 percent; and coronary-artery bypass surgery, 9 to 17 percent) and was lowest in New England. The regional use of cardiac procedures was closely related to their availability, except in New England. After the analysis was adjusted for clinical and hospital variables, patients in New England were found to be less likely to undergo angiography than patients in the other regions (odds ratio, 0.37; 95 percent confidence interval, 0.32 to 0.42). There was no apparent relation between the use of cardiac procedures and rates of recurrent infarction or death at 30 days or 1 year.

CONCLUSIONS

There is substantial regional variation in the use of cardiac medications and procedures to manage acute myocardial infarction in the United States. The use and availability of cardiac procedures are closely related. The management of acute myocardial infarction in New England is atypical in that the relatively limited availability of cardiac procedures does not account for their relatively low use in that region.

摘要

相似文献

1
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
N Engl J Med. 1995 Aug 31;333(9):565-72. doi: 10.1056/NEJM199508313330907.
2
Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.美国和加拿大急性心肌梗死患者的长期死亡率:对参与“冠状动脉闭塞时链激酶和组织型纤溶酶原激活剂的全球应用研究(GUSTO-I)”的患者的比较。
Circulation. 2004 Sep 28;110(13):1754-60. doi: 10.1161/01.CIR.0000142671.06167.91. Epub 2004 Sep 20.
3
Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.接受溶栓治疗的急性心肌梗死女性和男性患者的特征及预后比较。GUSTO-I研究组。
JAMA. 1996 Mar 13;275(10):777-82.
4
Influence of regional cardiovascular mortality on the use of angiography after acute myocardial infarction.
Am J Cardiol. 1997 Mar 1;79(5):575-80. doi: 10.1016/s0002-9149(96)00818-1.
5
Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study.在全球应用链激酶和组织型纤溶酶原激活剂治疗闭塞冠状动脉(GUSTO-I)试验中,积极的有创导管插入术和血运重建策略对心源性休克患者死亡率的影响。一项观察性研究。
Circulation. 1997 Jul 1;96(1):122-7. doi: 10.1161/01.cir.96.1.122.
6
Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.接受溶栓治疗的时间:急性心肌梗死短期非致命性结局的决定因素及影响。加拿大GUSTO研究人员。链激酶和组织型纤溶酶原激活剂在冠状动脉闭塞中的全球应用研究。
CMAJ. 1997 Feb 15;156(4):497-505.
7
Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigators.急性ST段抬高型心肌梗死治疗的时间演变:来自加拿大和美国的七年GUSTO经验。北美GUSTO - I和GUSTO - III研究人员
Can J Cardiol. 2000 Oct;16(10):1231-9.
8
Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.糖尿病对急性心肌梗死溶栓时代临床结局的影响。GUSTO-I研究人员。链激酶和组织型纤溶酶原激活剂在闭塞冠状动脉中的全球应用。
J Am Coll Cardiol. 1997 Jul;30(1):171-9. doi: 10.1016/s0735-1097(97)00118-6.
9
Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.美国及其他国家急性心肌梗死患者管理与治疗结果的差异。GUSTO试验结果。全球应用链激酶和组织型纤溶酶原激活剂治疗闭塞冠状动脉研究。
JAMA. 1995;273(20):1586-91. doi: 10.1001/jama.273.20.1586.
10
Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studies.
Circulation. 2001 Feb 20;103(7):954-60. doi: 10.1161/01.cir.103.7.954.

引用本文的文献

1
Geographic differences in the magnitude of black-white disparities in having obesity.肥胖方面黑人和白人差异程度的地域差异。
Obes Sci Pract. 2023 May 26;9(5):516-528. doi: 10.1002/osp4.679. eCollection 2023 Oct.
2
County-level variation in cardioprotective antihyperglycemic prescribing among medicare beneficiaries.医疗保险受益人心血管保护类降糖药物处方的县级差异。
Am J Prev Cardiol. 2022 Aug 2;11:100370. doi: 10.1016/j.ajpc.2022.100370. eCollection 2022 Sep.
3
Point-of-care testing with high-sensitivity cardiac troponin assays: the challenges and opportunities.
高敏心肌肌钙蛋白检测的即时检验:挑战与机遇
Emerg Med J. 2022 Nov;39(11):861-866. doi: 10.1136/emermed-2021-211907. Epub 2022 Jan 11.
4
Use of Cardiac Noninvasive Testing After Emergency Department Discharge: Association of Hospital Network Testing Intensity and Outcomes in Ontario, Canada.急诊科出院后进行心脏无创性检查的应用:加拿大安大略省医院网络检查强度与结果的相关性。
J Am Heart Assoc. 2020 Nov 3;9(21):e017330. doi: 10.1161/JAHA.120.017330. Epub 2020 Oct 22.
5
Regional Variation in the Management and Outcomes of Acute Myocardial Infarction With Cardiogenic Shock in the United States.美国伴心原性休克的急性心肌梗死的治疗和结局的地域差异。
Circ Heart Fail. 2020 Feb;13(2):e006661. doi: 10.1161/CIRCHEARTFAILURE.119.006661. Epub 2020 Feb 14.
6
The distribution of cardiac diagnostic testing for acute coronary syndrome in the Brazilian healthcare system: A national geospatial evaluation of health access.巴西医疗体系中急性冠脉综合征心脏诊断检测的分布:卫生服务可及性的全国地理空间评估。
PLoS One. 2019 Jan 10;14(1):e0210502. doi: 10.1371/journal.pone.0210502. eCollection 2019.
7
Variation in Management of Patients With Obstructive Coronary Artery Disease: Insights From the Veterans Affairs Clinical Assessment and Reporting Tool (VA CART) Program.患者患有阻塞性冠状动脉疾病的管理方法存在差异:来自退伍军人事务临床评估和报告工具(VA CART)计划的见解。
J Am Heart Assoc. 2017 Sep 12;6(9):e006336. doi: 10.1161/JAHA.117.006336.
8
Regional Variation in Postoperative Myocardial Infarction in Patients Undergoing Vascular Surgery in the United States.美国血管手术患者术后心肌梗死的区域差异。
Ann Vasc Surg. 2017 Apr;40:63-73. doi: 10.1016/j.avsg.2016.07.099. Epub 2016 Nov 29.
9
Medicare and Private Insurance Variations in New Medical Technology: The Case of Drug Eluting Stents.医疗保险与新型医疗技术中的私人保险差异:以药物洗脱支架为例。
Health Econ Outcome Res. 2016 Jun;2(2). Epub 2016 May 18.
10
Geographic variation in the treatment of non-ST-segment myocardial infarction in the English National Health Service: a cohort study.英国国民医疗服务体系中非ST段抬高型心肌梗死治疗的地域差异:一项队列研究。
BMJ Open. 2016 Jul 12;6(7):e011600. doi: 10.1136/bmjopen-2016-011600.